Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

Delayed Quote. Delayed  - 02/05 04:00:01 pm
68.41 USD   -3.85%
01/28 BIOMARIN TO HOS : 30pm ET
01/19 NASDAQ 100 MOVE : Bmrn, viab
01/15 BIOMARIN PHARMA : FDA Issues Complete Response Letter for KyndrisaTM..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo BioMarin Pharmaceutical In
Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions.

It operates its business through one segment, the biopharmaceutical development and commercialization segment.

Its company's products include Naglazyme, Kuvan, Aldurazyme, Firdapse and VIMIZIM.

The company was founded on March 21, 1997 and is headquartered in Novato, CA.

Number of employees : 1 681 persons.
Sales per Businesses
20132014Delta
USD (in Million)%USD (in Million)%
Biopharmaceutical Development and Commercialization548.49100%751.04100.1% +26.97%
Sales per Regions
20132014Delta
USD (in Million)%USD (in Million)%
United States277.5050.6%380.0450.7% +26.98%
Europe116.9021.3%139.9418.7% +16.47%
Rest of World76.6314%112.4915% +31.88%
Latin America67.3412.3%118.5615.8% +43.2%
Managers
NameAgeSinceTitle
Jean-Jacques Bienaimé622005Chairman & Chief Executive Officer
Daniel K. Spiegelman, MBA572012Chief Financial Officer & Executive Vice President
Henry J. Fuchs, MD582009Chief Medical Officer & Executive Vice President
Eduardo E. Von Pervieux, MBA-2008Chief Information Officer & Vice President
Pierre LaPalme752004Director
Elaine J. Heron PhD, MBA682002Independent Non-Executive Director
Mike G. Grey632005Independent Non-Executive Director
Richard A. Meier562006Lead Independent Non-Executive Director
V. Bryan Lawlis Jr., PhD642007Independent Non-Executive Director
Alan J. Lewis, PhD702005Independent Non-Executive Director
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 18,940,220 11.7%
Fidelity Management & Research Co. 14,655,204 9.09%
Sands Capital Management LLC 11,395,866 7.07%
The Vanguard Group, Inc. 10,840,150 6.72%
BlackRock Fund Advisors 7,649,941 4.74%
T. Rowe Price Associates, Inc. 7,535,694 4.67%
PRIMECAP Management Co. 7,365,039 4.57%
Jennison Associates LLC 4,952,023 3.07%
JPMorgan Investment Management, Inc. 4,318,559 2.68%
Baker Bros. Advisors LP 4,076,353 2.53%
Holdings
NameEquities%Valuation
Catalyst Pharmaceuticals Inc (CPRX) 6,666,6678.05%16,333,334 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Generic Pharmaceuticals
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
SUN PHARMACEUTICA..
ONO PHARMACEUTICA..
OTSUKA HOLDINGS C..
ENDO INTERNATIONA..
BIOMARIN PHARMACE..
HANMI SCIENCE CO ..
-
ASPEN PHARMACARE ..
CIPLA LTD
TAISHO PHARMACEUT..
HANMIPHARM
SHANGHAI FOSUN PH..
SIHUAN PHARMACEUT..
CADILA HEALTHCARE..
HUNAN ER-KANG PHA..
DIVI'S LABORATORI..
SHENZHEN SALUBRIS..
RICHTER GEDEON VE..
SHENZHEN HEPALINK..
-
SICHUAN KELUN PHA..
-
GLENMARK PHARMACE..
Sector Pharmaceuticals
BioMarin Pharmaceutical In : Connections
Algorithme Pharma, Inc.
DiaVacs, Inc.
Amplyx Pharmaceuticals, Inc.
Pediapharm Inc
Zephyrus Biosciences, Inc.
Rincon Pharmaceuticals, Inc.
Cellastra, Inc.
Reneo Pharmaceuticals, Inc.
GLyPharma Therapeutic, Inc.
Targazyme, Inc.
GlycoFi, Inc.
Reform Biologics LLC
Ziarco Group Ltd.
Ziarco Pharma Ltd.
Itero Biopharmaceuticals LLC
Selventa, Inc.
Sutro Biopharma, Inc.
Rapidscan Pharma Solutions, Inc.
Cytochroma, Inc.
Balance Therapeutics, Inc.
Batu Biologics, Inc.
A. M. Pappas & Associates LLC
Sosei Co. Ltd.
Biotechnology Industry Organization
Aerogen, Inc.
Capella Therapeutics, Inc.
Company contact information
770 street Lindaro
CA 94901 San Rafael, California
États-Unis (les)

Phone : +1 415-506-6700
Fax : +1 415-382-7889
Internet : http://www.bmrn.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- ISIN Code :  US09061G1013
- Bloomberg Code :  
- Reuters Code :  BMRN.O
- Datastream Code :  
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem